Is decaffeinated coffee carcinogenic?

Is Decaffeinated Coffee Carcinogenic?

Decaffeinated coffee is not carcinogenic and does not increase overall cancer risk, though recent evidence suggests a potential concern for bladder cancer specifically in male never-smokers that warrants caution. 1

Overall Cancer Risk Assessment

The evidence strongly indicates that decaffeinated coffee consumption does not increase total cancer risk. The most comprehensive and recent prospective cohort study (2025) following 121,337 participants for up to 36 years found no association between decaffeinated coffee intake and overall cancer risk (HR 1.00 per cup/day). 1

Acrylamide Concerns Are Not Supported by Human Evidence

While coffee (including decaffeinated) contains acrylamide—a chemical formed during high-temperature processing—the American Cancer Society guideline explicitly addresses this concern:

• Acrylamide is classified by IARC as a "probable carcinogen" based primarily on animal experiments 2
• However, large numbers of epidemiologic studies in humans have found no strong evidence that dietary acrylamide exposure is associated with cancer risk 2
• This reassurance applies to coffee consumption generally, including decaffeinated varieties 2

Site-Specific Cancer Evidence

Protective Associations

Decaffeinated coffee shows protective effects for certain cancers:

• Colorectal cancer: Consumption of ≥2 cups/day associated with 18% lower risk (HR 0.82) 1, 3
• Colon cancer: Similar 18% risk reduction (HR 0.82) 1, 3
• Rectal cancer: 37% lower risk (HR 0.63) with ≥2 cups/day 1, 3
• Aggressive prostate cancer: 7% lower risk per cup/day (HR 0.93) 1

No Association Found

• Gastric cancer: No significant association with decaffeinated coffee consumption 4
• Lung cancer: Initial positive association completely attenuated when restricted to never-smokers, indicating confounding by smoking 1

Critical Concern: Bladder Cancer in Men

The most important finding requiring clinical attention is an elevated bladder cancer risk specifically among male never-smokers:

• Compared to non-drinkers, male never-smokers consuming decaffeinated coffee showed dose-dependent increased risk 1:
  • 0.1-0.9 cups/day: HR 1.30
  • 1-1.9 cups/day: HR 1.42
  • 2-2.9 cups/day: HR 1.43
  • ≥3 cups/day: HR 1.79
• This association remained robust across multiple sensitivity analyses and strengthened with 8-year lag analysis 1
• No such association was observed in women (significant sex heterogeneity, P=0.03) 1
• The mechanism may relate to methylene chloride residue from the decaffeination process, which has known carcinogenic properties 1

Clinical Recommendations

For the general population: Decaffeinated coffee can be safely consumed as part of a healthy diet, with potential protective benefits for colorectal and prostate cancers 5, 1

For male never-smokers with bladder cancer risk factors: Consider limiting or avoiding decaffeinated coffee consumption given the observed dose-dependent increased risk, though this finding requires confirmation in additional studies 1

Phenolic compounds are preserved: Decaffeinated coffee retains most of the beneficial phenolic acids and flavonoids associated with health benefits, making it a reasonable alternative for those avoiding caffeine 5

Important Caveat

The bladder cancer finding in men is from a single, albeit high-quality and large prospective study published in 2025. The authors themselves note this warrants further investigation before definitive conclusions 1. However, given the dose-response relationship, biological plausibility through methylene chloride exposure, and robust sensitivity analyses, prudent clinical practice would involve counseling male patients, particularly never-smokers, about this potential risk.